A reminder that many disruptive advances in metabolic care are ultimately the result of basic science, translational discipline, and decades of iteration, not overnight innovation
PsA Disease Activity Improves on GLP-1s A retrospective study presented at ACR Convergence 2025, led by researchers from the University of Toronto and NYU, followed 48 patients with psoriatic arthritis who started GLP-1 receptor agonists. The findings: Significant weight loss (35% of patients lost 510% of body weight
If youre considering a safe, evidence-based approach to weight management, Ozempic could be the ideal option for you
semaglutide GLP-1 addresses the bodys resistance to burning calories by combating factors such as slowed metabolism and hunger-inducing hormones
It is becoming central to our understanding of metabolic health, immune function , neurological health, and aging
Patients should consult their healthcare provider before using antiemetic medications for symptom management